Merck bows to pressure
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.MERCK & CO, the leading US pharmaceutical company and the world's largest maker of prescription drugs, has agreed to sign a three-year contract with the US government restricting its price increases. The move appears to be one of the first in Hillary Clinton's reorganisation of the US health sector, which is expected to lead to widespread cuts in drug prices.
Merck said it had put forward a proposal that would limit drug companies' annual price increases for entire product lines to the rise in the consumer price index. It also proposes limiting annual drug price increases to the rate of inflation plus one percentage point.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments